TTK Healthcare
Ticker > Company >

TTK Healthcare share price

TTK Healthcare Ltd.

NSE: TTKHLTCARE BSE: 507747 SECTOR: Diversified  56.81 K   65   5

1171.80
+29.15 (2.55%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 1171.8

Today's Low

₹ 1160

52 Week High

₹ 1822.2

52 Week Low

₹ 991

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1655.79 Cr.

Enterprise Value

₹ 891.24 Cr.

No. of Shares

1.41 Cr.

P/E

26.25

P/B

1.54

Face Value

₹ 10

Div. Yield

0.85 %

Book Value (TTM)

₹  759.81

CASH

₹ 786.49 Cr.

DEBT

₹ 21.94 Cr.

Promoter Holding

74.56 %

EPS (TTM)

₹  44.64

Sales Growth

6.47%

ROE

7.94 %

ROCE

10.63%

Profit Growth

29.94 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.47%
3 Year10.18%
5 Year4.42%

Profit Growth

1 Year29.94%
3 Year25.22%
5 Year45.98%

ROE%

1 Year7.94%
3 Year7.14%
5 Year8.24%

ROCE %

1 Year10.63%
3 Year9.83%
5 Year9.29%

Debt/Equity

0.0207

Price to Cash Flow

-416.48

Interest Cover Ratio

33.5888

CFO/PAT (5 Yr. Avg.)

0.440513035745112

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 74.56 0.00
Mar 2025 74.56 0.00
Dec 2024 74.56 0.00
Sep 2024 74.56 0.00
Jun 2024 74.56 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 64.0063231901425% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 33.5888.
  • Company’s PEG ratio is 0.876705407901839.
  • The company has an efficient Cash Conversion Cycle of -18.9066 days.
  • Company has a healthy liquidity position with current ratio of 5.2336.
  • The company has a high promoter holding of 74.56%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.27420382979308.

 Limitations

  • The company has shown a poor revenue growth of 10.179125628496% for the Past 3 years.
  • Company has a poor ROE of 7.1368% over the past 3 years.
  • Company has negative cash flow from operations of -3.9757.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 207.9 198.49 204.75 190.36 226.43
Total Expenditure 201 190.26 197.05 178.36 223.75
Operating Profit 6.91 8.23 7.69 12 2.68
Other Income 17.03 17.7 17.84 18.69 17.94
Interest 0.86 0.74 0.82 0.91 0.77
Depreciation 2.05 2.01 2.11 2.17 2.19
Exceptional Items 19.77 0 0 -5.86 0
Profit Before Tax 40.79 23.19 22.6 21.76 17.65
Tax 9.22 5.99 5.86 5.61 4.65
Profit After Tax 31.58 17.2 16.73 16.15 13
Adjusted EPS (Rs) 22.35 12.17 11.84 11.43 9.2

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 476.06 599.24 725.11 752.79 801.49
Total Expenditure 456.74 577.4 693.76 715.47 766.67
Operating Profit 19.32 21.84 31.35 37.33 34.83
Other Income 9.93 16.33 48.33 62.61 71.25
Interest 1.71 3.24 5.24 2.76 3.32
Depreciation 13.02 12.58 12.81 13.06 8.33
Exceptional Items 8.1 2.49 0 0 13.91
Profit Before Tax 22.62 24.84 61.64 84.12 108.33
Tax -14.16 6.33 16.97 21.28 26.67
Net Profit 46.44 41.59 639.71 62.84 81.66
Adjusted EPS (Rs.) 26.03 13.1 31.61 44.47 57.79

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 14.13 14.13 14.13 14.13 14.13
Total Reserves 280.52 315.5 939.25 986.79 1050.92
Borrowings 0 0 0 0 0
Other N/C liabilities 4.41 1.08 1.59 -1.58 -0.74
Current liabilities 188.76 199.05 210.78 201.52 210.92
Total Liabilities 487.82 551.25 1165.75 1200.86 1275.24
Assets
Net Block 85.35 80.27 71.19 74.81 80.9
Capital WIP 0.45 0.19 2.79 0.79 0.08
Intangible WIP 0 0 0 0 0
Investments 13.17 15.13 12.85 12.56 11.22
Loans & Advances 13.62 6.81 11.58 12.31 12.25
Other N/C Assets 0 24.29 1.27 23.09 66.9
Current Assets 375.25 424.55 1066.07 1077.3 1103.89
Total Assets 487.82 551.25 1165.75 1200.86 1275.24
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 37.05 57.78 838.07 84.12 108.33
Adjustment -2.53 0.24 -803.09 -48.77 -81.37
Changes in Assets & Liabilities 41.58 -3.84 -43.9 -15.33 -3.12
Tax Paid 20.32 -9.18 -15.9 -24.96 -27.81
Operating Cash Flow 96.42 45 -24.81 -4.94 -3.98
Investing Cash Flow -77.24 -29.56 31.69 28.49 20.1
Financing Cash Flow -17.16 -10.13 -12.43 -21.91 -18.08
Net Cash Flow 2.03 5.31 -5.54 1.64 -1.95

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 74.56 74.56 74.56 74.56 74.56
bhanu raghunathan 0.40 0.40 0.40 0.40 0.40
latha jagannathan 0.21 0.21 0.21 0.21 0.21
mukund thiruvallur thatta... 0.10 0.10 0.10 0.10 0.10
packwell packaging produc... 0.06 0.06 0.06 0.06 0.06
shanthi ranganathan 0.41 0.41 0.41 0.41 0.41
t t krishnamachari & co. ... 67.46 67.46 67.46 67.46 67.46
t t raghunathan 0.27 0.27 0.27 0.27 0.27
thiruvallur thattai jagan... 5.37 5.37 5.37 5.37 5.37
thiruvallur thattai venka... 0.10 0.10 0.10 0.10 0.10
tiruvallur thatai lakshma... 0.10 0.10 0.10 0.10 0.10
ttk prestige limited 0.01 0.01 0.01 0.01 0.01
ttk tantex limited 0.06 0.06 0.06 0.06 0.06
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 25.44 25.44 25.44 25.44 25.44
abakkus diversified alpha... 1.13 1.13 1.13 1.13 1.13
investor education and pr... 1.03 1.07 1.07 0.85 1.06
jupiter india fund 1.52 1.52 1.52 1.52 1.52
vidhit tulshan 1.04 1.04 1.04 1.04 1.02
uno metals ltd - 1.59 - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

TTK Healthcare Stock Price Analysis and Quick Research Report. Is TTK Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse TTK Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). TTK Healthcare has a PE ratio of 26.1097658498778 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. TTK Healthcare has ROA of 6.5956% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. TTK Healthcare has a Current ratio of 5.2336.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. TTK Healthcare has a ROE of 7.9389%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. TTK Healthcare has a Debt to Equity ratio of 0.0207 which means that the company has low proportion of debt in its capital.

  • Sales growth: TTK Healthcare has reported revenue growth of 6.4692% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of TTK Healthcare for the current financial year is 4.34541319990906%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for TTK Healthcare is Rs 10 and the yield is 0.8534%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of TTK Healthcare is Rs 44.6423. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of TTK Healthcare in Ticker for free. Also, one can get the intrinsic value of TTK Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

TTK Healthcare FAQs

Q1. What is TTK Healthcare share price today?
Ans: The current share price of TTK Healthcare is Rs 1165.6.

Q2. What is the market capitalisation of TTK Healthcare?
Ans: TTK Healthcare has a market capitalisation of Rs 1647.03161448 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of TTK Healthcare?
Ans: The PE ratio of TTK Healthcare is 26.1097658498778 and the P/B ratio of TTK Healthcare is 1.53407338072079, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of TTK Healthcare share?
Ans: The 52-week high share price of TTK Healthcare is Rs 1827.85, and the 52-week low share price of TTK Healthcare is Rs 1101.05.

Q5. Does TTK Healthcare pay dividends?
Ans: Currently, TTK Healthcare pays dividends. Dividend yield of TTK Healthcare is around 0.8534%.

Q6. What are the face value and book value of TTK Healthcare shares?
Ans: The face value of TTK Healthcare shares is Rs 10, while the book value per share of TTK Healthcare is around Rs 759.8072. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of TTK Healthcare?
Ans: TTK Healthcare has a total debt of Rs 21.9351 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of TTK Healthcare?
Ans: The ROE of TTK Healthcare is 7.9389% and ROCE of TTK Healthcare is 10.6311%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is TTK Healthcare a good buy for the long term?
Ans: The TTK Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is TTK Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the TTK Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check TTK Healthcare’s financials?
Ans: You can review TTK Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about TTK Healthcare
X